the news highlighted another factor in the chinese threat: regardless of the different regulatory framework, many researchers think the data they report is valid.
.
.
/
.
.
“it may be just out of an abundance of caution and privacy. certainly, staying a little longer may imply that this is a little bit more of a complex situation.”
. and be the first to know about traffic alerts, weather updates and breaking stories from across maine.
.
'indian ip and liabilities law barrier to pharma r&d investment'